Interferon beta-1a
Showing 26 - 50 of >10,000
Merkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7 Trial in Seattle (drug, other, biological, radiation)
Terminated
- Merkel Cell Polyomavirus Infection
- Stage IV Merkel Cell Carcinoma AJCC v7
- Avelumab
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Feb 25, 2022
US PROmyBETAapp2.0: A Study to Learn More About Medication Usage
Completed
- Multiple Sclerosis
- Interferon-beta-1b (BETASERON, BAY 86-5046)
-
Whippany, New JerseymyBETAapp
Mar 2, 2022
Relapsing Remitting Multiple Sclerosis Trial in Portugal (peginterferon beta-1a, interferon beta-1a, interferon beta-1b)
Completed
- Relapsing Remitting Multiple Sclerosis
- peginterferon beta-1a
- +2 more
-
Amadora, Portugal
- +14 more
Nov 23, 2020
Multiple Sclerosis Trial in Worldwide (Ofatumumab, First line DMT)
Recruiting
- Multiple Sclerosis
- Ofatumumab
- First line DMT
-
Bayonne, Bayonne Cedex, France
- +42 more
Jul 25, 2022
Bioequivalence, Healthy Trial in Turku (Interferon Beta-1A)
Completed
- Bioequivalence
- Healthy
- Interferon Beta-1A
-
Turku, FinlandCRST Oy, Clinical Research Services Turku Itäinen Pitkäkatu 4 B,
Jan 8, 2020
COVID-19, INTERFERON, NEBULIZATION Trial in France (inhaled type I interferon, WFI water nebulization)
Recruiting
- COVID-19
- +2 more
- inhaled type I interferon
- WFI water nebulization
-
Abbeville, France
- +6 more
Jan 3, 2022
Worldwide Trends on COVID-19 Research After Declaration of
Unknown status
- COVID-19
- Convalescent Plasma Transfusion
- +4 more
- (no location specified)
Jul 3, 2020
Sarcoma, Kaposi, HIV Trial in Los Angeles, Chicago (Interferon beta-1b, Zidovudine)
Completed
- Sarcoma, Kaposi
- HIV Infections
- Interferon beta-1b
- Zidovudine
-
Los Angeles, California
- +3 more
Oct 26, 2021
HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1
Recruiting
- HLA-A2 Positive Cells Present
- Refractory Melanoma
- Alpha-type-1 Polarized Dendritic Cells
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 12, 2022
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Trial in Riyadh (Combination of Lopinavir /Ritonavir and Interferon
Completed
- Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
- Combination of Lopinavir /Ritonavir and Interferon beta-1b
- Placebo
-
Riyadh, Saudi Arabia
- +1 more
May 18, 2020
Multiple Sclerosis (MS) Germany Treated With Betaferon
Completed
- Multiple Sclerosis
- Interferon beta-1b (Betaferon, BAY86-5046)
- Betaconnect Autoinjector
-
Multiple Locations, Germany(unnamed)
Jan 15, 2021
Multiple Sclerosis Trial in Worldwide (Alemtuzumab GZ402673, Glatiramer acetate, Beta-Interferon)
Active, not recruiting
- Multiple Sclerosis
- Alemtuzumab GZ402673
- +11 more
-
Wien, Austria
- +20 more
Jun 16, 2022
Chronic Pulmonary Aspergillosis, Aspergillosis Trial (Interferon Gamma-1B 0.1 MG Per 0.5 ML Injection PLUS antifungals as
Not yet recruiting
- Chronic Pulmonary Aspergillosis
- Aspergillosis
- Interferon Gamma-1B 0.1 MG Per 0.5 ML Injection PLUS antifungals as standard of care
- Antifungals as standard of care
- (no location specified)
Dec 13, 2022
MS (Multiple Sclerosis), Erythema Trial in Kirkland (Warm Compress Before Injection, Cold Compress After Injection)
Completed
- MS (Multiple Sclerosis)
- Erythema
- Warm Compress Before Injection
- Cold Compress After Injection
-
Kirkland, WashingtonEvergreen Health
Mar 10, 2022
Multiple Sclerosis Trial in Buffalo (repository corticotropin injection, Saline)
Withdrawn
- Multiple Sclerosis
- repository corticotropin injection
- Saline
-
Buffalo, New YorkUniversity at Buffalo, Buffalo General Hospital
Dec 30, 2020
COVID-19 Trial in Tehran (Umifenovir, Interferon-ß 1a, Lopinavir / Ritonavir)
Unknown status
- COVID-19
- Umifenovir
- +4 more
-
Tehran, Iran, Islamic Republic ofLoghman Hakim Hospital, Shahid Beheshti University of Medical Sc
Apr 16, 2020
Relapsing Remitting Multiple Sclerosis Trial (Laquinimod, Avonex®)
Withdrawn
- Relapsing Remitting Multiple Sclerosis
- (no location specified)
Nov 5, 2021
Lactose Intolerance Trial in West Lafayette (Milk containing A1 and A2 beta-casein, Milk containing only A2 beta-casein)
Recruiting
- Lactose Intolerance
- Milk containing A1 and A2 beta-casein
- Milk containing only A2 beta-casein
-
West Lafayette, IndianaPurdue University
Dec 20, 2022
Lactose Intolerance, Adult Type Trial in West Lafayette (Milk containing A1 and A2 beta-casein, Milk containing only A2
Active, not recruiting
- Lactose Intolerance, Adult Type
- Milk containing A1 and A2 beta-casein
- Milk containing only A2 beta-casein
-
West Lafayette, IndianaPurdue MRI Facility
Dec 17, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Biopsy
- +7 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Feb 23, 2023
Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (Dimethyl Fumarate, Peginterferon Beta-1a, Placebo)
Terminated
- Multiple Sclerosis, Relapsing-Remitting
- Dimethyl Fumarate
- +2 more
-
Raleigh, North Carolina
- +22 more
Nov 30, 2022
Corona Virus Infection Trial in Worldwide (Remdesivir, Lopinavir/ritonavir, Interferon Beta-1A)
Active, not recruiting
- Corona Virus Infection
- Remdesivir
- +6 more
-
Innsbruck, Austria
- +61 more
Jul 1, 2022
Multiple Sclerosis Trial in Teaneck (Plegridy, Prednisone, Tylenol Pill)
Unknown status
- Multiple Sclerosis
- Plegridy
- +2 more
-
Teaneck, New JerseyHoly Name Medical Center
Aug 13, 2019